Long-term clinical outcomes in patients with chronic hepatitis delta: the role of persistent viraemia.
Adriana PalomSergio Rodríguez-TajesCarmen A NavascuésJavier García-SamaniegoMar RiveiroSabela LensManuel RodríguezRafael EstebanMaria Buti FerretPublished in: Alimentary pharmacology & therapeutics (2019)
Subjects with persistently positive HDV-RNA had a worse prognosis in terms of clinical events. Baseline-event-anticipation score is useful in predicting the risk of developing liver decompensation and hepatocellular carcinoma. Interferon was beneficial in reducing liver decompensation, even in the absence of virological response.